Ludmila Danilova
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 16
- Pancreatic and Hepatic Oncology Research 6
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 10
- Immunology top 5%
- Immunotherapy and Immune Responses 6
- Otorhinolaryngology top 5%
-
- Epigenetics and DNA Methylation 15
- Cancer-related gene regulation 10
- Single-cell and spatial transcriptomics 8
- RNA modifications and cancer 6
- Co-authors
- Robert A. AndersElana J. FertigDrew M. PardollJanis M. TaubeHao WangAlexander V. FavorovMark YarchoanElizabeth M. Jaffee
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- United StatesRussiaJapan
In The Last Decade
Ludmila Danilova
61 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Oncology 1.0k
- Cancer Research 536
- Immunology 555
- Pulmonary and Respiratory Medicine 539
- Otorhinolaryngology 68
Countries citing papers authored by Ludmila Danilova
This map shows the geographic impact of Ludmila Danilova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludmila Danilova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludmila Danilova more than expected).
Fields of papers citing papers by Ludmila Danilova
This network shows the impact of papers produced by Ludmila Danilova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludmila Danilova. The network helps show where Ludmila Danilova may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ludmila Danilova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 18 | |
| 5 | 2023 | 56 | |
| 6 | 2022 | 13 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 15 | |
| 9 | 2020 | 28 | |
| 10 | 2020 | 22 | |
| 11 | 2020 | 21 | |
| 12 | 2019 | 180 | |
| 13 | 2018 | 99 | |
| 14 | 2018 | 144 | |
| 15 | 2018 | 6 | |
| 16 | 2017 | 33 | |
| 17 | 2016 | 133 | |
| 18 | 2014 | 65 | |
| 19 | 2013 | 68 | |
| 20 | 2013 | 30 |
About Ludmila Danilova
Ludmila Danilova is a scholar working on Cancer Research, Oncology and Immunology, having authored 65 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (16 papers), Epigenetics and DNA Methylation (15 papers), Cancer Genomics and Diagnostics (10 papers), Cancer-related gene regulation (10 papers), Single-cell and spatial transcriptomics (8 papers), Pancreatic and Hepatic Oncology Research (6 papers), Immunotherapy and Immune Responses (6 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (536 citations) and Immunology (555 citations). Ludmila Danilova has collaborated with scholars based in United States, Russia and Japan. Frequent co-authors include Robert A. Anders, Elana J. Fertig, Drew M. Pardoll, Janis M. Taube, Hao Wang, Alexander V. Favorov, Mark Yarchoan, Elizabeth M. Jaffee, Julie E. Stein and Leslie Cope. Their work appears in journals such as Cancer Research, Cancer Immunology Research, Epigenetics, Proceedings of the National Academy of Sciences and Genome Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.